» Articles » PMID: 971732

Synthesis of Eel-calcitonin and (asu1,7)-eel-calcitonin: Contribution of the Disulfide Bond to the Hormonal Activity

Overview
Journal Experientia
Specialty Science
Date 1976 Sep 15
PMID 971732
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Eel-calcitonin and its [asu1,7]-analog, deamino-dicarba-analog, were synthesized by the conventional solution method. The natural-type product showed 4300 MRC U/mg in the hypocalcemic potency which was comparable to that of the natural hormone isolated from eel. Hormonal activity of the Asu-analog was also as high as 3400 MRC U/mg.

Citing Articles

Mono and dual agonists of the amylin, calcitonin, and CGRP receptors and their potential in metabolic diseases.

Sonne N, Karsdal M, Henriksen K Mol Metab. 2020; 46:101109.

PMID: 33166741 PMC: 8085567. DOI: 10.1016/j.molmet.2020.101109.


Calcitonin and Bone Physiology: In Vitro, In Vivo, and Clinical Investigations.

Xie J, Guo J, Kanwal Z, Wu M, Lv X, Ibrahim N Int J Endocrinol. 2020; 2020:3236828.

PMID: 32963524 PMC: 7501564. DOI: 10.1155/2020/3236828.


Efficacy and safety of elcatonin in postmenopausal women with osteoporosis: a systematic review with network meta-analysis of randomized clinical trials.

Chen W, Lin E, Kang Y Osteoporos Int. 2019; 30(9):1723-1732.

PMID: 31041475 DOI: 10.1007/s00198-019-04997-6.


Effectiveness of elcatonin for alleviating pain and inhibiting bone resorption in patients with osteoporotic vertebral fractures.

Tanaka S, Yoshida A, Kono S, Oguma T, Hasegawa K, Ito M J Bone Miner Metab. 2016; 35(5):544-553.

PMID: 27830386 DOI: 10.1007/s00774-016-0791-6.


Improvement of Quality of Life (QOL) in Osteoporotic Patients by Elcatonin Treatment: A Trial Taking the Participants' Preference into Account.

Yoh K, Uzawa T, Orito T, Tanaka K Jpn Clin Med. 2013; 3:9-14.

PMID: 23946680 PMC: 3738553. DOI: 10.4137/JCM.S8291.


References
1.
ODor R, Parkes C, Copp D . Amino acid composition of salmon calcitonin. Can J Biochem. 1969; 47(8):823-5. DOI: 10.1139/o69-128. View

2.
Niall H, Keutmann H, Copp D, Potts Jr J . Amino acid sequence of salmon ultimobranchial calcitonin. Proc Natl Acad Sci U S A. 1969; 64(2):771-8. PMC: 223410. DOI: 10.1073/pnas.64.2.771. View

3.
Rittel W, Maier R, Brugger M, Kamber B, RINIKER B, Sieber P . [Structure-activity relationship of human calcitonin. III. Biological activity of synthetic analogues with shortened or terminally modified peptide chains (author's transl)]. Experientia. 1976; 32(2):246-8. DOI: 10.1007/BF01937791. View

4.
Sakakibara S, Shimonishi Y . A new method for releasing oxytocin from fully-protected nona-peptides using anhydrous hydrogen fluoride. Bull Chem Soc Jpn. 1965; 38(8):1412-3. DOI: 10.1246/bcsj.38.1412. View

5.
Keutmann H, Parsons J, Potts Jr J, SCHLUETER R . Isolation and chemical properties of two calcitonins from salmon ultimobranchial glands. J Biol Chem. 1970; 245(6):1491-6. View